Ruxolitinib add-on in corticosteroid-refractory graft-vs-host disease after allogeneic stem cell transplantation: Results from a retrospective study on 38 Chinese patients

por Dang, Si-Hua, Liu, Qin, Xie, Rong, Shen, Na, Zhou, Shu, Shi, Wei, Liu, Wen, Zou, Ping, You, Yong, Zhong, Zhao-Dong
Publicado 2020